Celldex Therapeutics | CLDX - SCHULD





SCHULD Veränderung Datum
AbbVie USD 67.5B 67.5B 2025-12
Agenus USD 35.54M 2.34M 2025-03
Amgen USD 54.6B 17M 2025-12
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Celldex Therapeutics USD 2.34M 285K 2025-12
Glaxosmithkline GBP 17.75B 396M 2025-09
Nektar Therapeutics USD 0 0 2022-06
Northwest Biotherapeutics USD 32.94M 6.93M 2023-09
Pfizer USD 63.73B 231M 2026-03
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Roche Holding CHF 33.03B 1.41B 2025-06